Physician
ST. Mary's Regional Medical Center
ST. Mary's Regional Medical Center was paid $67.30M by Medicaid between Jan 2018 and Dec 2024, across 564 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 21% of everything it billed.
33Billing provider infoST. MARY'S REGIONAL MEDICAL CENTER
LEWISTON, ME 04240
LEWISTON, ME 04240
33aNPI1447226584assigned 02/28/2006
33bProvider typePsychiatry Physician
28Total paid$67.30M
24GClaims2,092,195
24DCodes billed564
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Psychiatry Physician providers in Maine
Rank by total paid#1 of 28
Median peer was paid$52K
This provider vs. median1,295×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 259,349 | $7.21M | |
| 2019 | 310,885 | $8.51M | |
| 2020 | 252,881 | $7.63M | |
| 2021 | 320,200 | $10.29M | |
| 2022 | 317,315 | $10.67M | |
| 2023 | 336,547 | $11.45M | |
| 2024incomplete | 295,018 | $11.55M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 21% | 230,408 | 176,560 | $13.85M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 10% | 69,295 | 63,319 | $6.80M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.1% | 47,725 | 43,504 | $6.10M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.8% | 18,756 | 16,361 | $5.90M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.6% | 96,339 | 85,124 | $3.10M |
| H2012 | Behavioral health day treatment, per hour | 4.5% | 40,954 | 1,610 | $3.04M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.6% | 74,777 | 60,434 | $1.77M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.8% | 20,936 | 19,469 | $1.23M |
| 90792 | Psychiatric diagnostic evaluation with medical services | 1.8% | 18,945 | 17,793 | $1.21M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.6% | 11,409 | 9,955 | $1.06M |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 1.4% | 5,160 | 4,455 | $944K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.3% | 13,464 | 12,394 | $877K |
552 more codes
| J0585 | Injection, onabotulinumtoxina, 1 unit | 1.2% | 2,404 | $811K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.1% | 5,004 | $733K |
| 99232 | Hospital visit by a doctor, follow-up day | 1.1% | 22,185 | $728K |
| 20610 | <1% | 7,799 | $608K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 31,569 | $548K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 7,725 | $548K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 1,635 | $522K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 6,560 | $494K |
| 29581 | <1% | 16,074 | $483K | |
| A0429 | Emergency ambulance ride, basic life support | <1% | 2,760 | $472K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13,181 | $471K |
| 20553 | <1% | 5,767 | $434K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 6,892 | $406K |
| A0425 | Ground mileage, per statute mile | <1% | 13,217 | $387K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 10,022 | $358K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 2,091 | $345K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 3,042 | $323K |
| 99223 | Prolong inpt eval add15 m | <1% | 3,338 | $317K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 6,053 | $311K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,275 | $310K |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 4,884 | $298K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 3,503 | $292K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 9,800 | $289K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 4,026 | $268K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 2,819 | $259K |
| 59025 | Fetal non-stress test | <1% | 2,371 | $258K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 4,835 | $244K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 7,161 | $229K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 544 | $205K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 12,368 | $205K |
| 71045 | Radiologic examination, chest; single view | <1% | 6,396 | $199K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 25,913 | $196K |
| 80053 | Comprehensive metabolic panel | <1% | 67,599 | $195K |
| 64493 | <1% | 674 | $195K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 3,621 | $190K |
| 90870 | <1% | 1,833 | $187K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 1,309 | $172K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 3,399 | $172K |
| 80061 | Lipid panel | <1% | 23,715 | $169K |
| 94060 | <1% | 1,965 | $148K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 191 | $145K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 1,061 | $142K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 3,003 | $141K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 10,239 | $139K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,352 | $137K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 1,426 | $136K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 10,265 | $135K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 10,263 | $135K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,211 | $131K |
| 76830 | Ultrasound, transvaginal | <1% | 2,021 | $131K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 762 | $130K |
| 29580 | <1% | 3,607 | $129K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 2,416 | $123K |
| 64615 | <1% | 1,421 | $120K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 67,354 | $119K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 14,413 | $119K |
| 76801 | <1% | 1,490 | $114K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 2,767 | $111K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 7,878 | $110K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 5,627 | $105K |
| 97161 | <1% | 3,581 | $102K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,588 | $100K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 24,152 | $97K |
| 90899 | <1% | 4,157 | $93K | |
| 86481 | <1% | 2,109 | $93K | |
| 93971 | <1% | 2,083 | $92K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 4,871 | $92K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,191 | $84K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,215 | $83K |
| 71250 | <1% | 2,208 | $83K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 18,621 | $82K |
| 86900 | <1% | 3,891 | $76K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 111,235 | $75K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 10,497 | $74K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 2,686 | $71K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 3,630 | $70K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 6,250 | $70K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 912 | $70K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 19,577 | $64K |
| 95811 | <1% | 184 | $57K | |
| 97162 | <1% | 2,119 | $56K | |
| 90686 | <1% | 4,794 | $56K | |
| 90677 | <1% | 363 | $53K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 2,099 | $53K |
| 82728 | <1% | 7,530 | $52K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 2,193 | $52K |
| 72141 | <1% | 434 | $52K | |
| 52000 | <1% | 328 | $51K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,176 | $50K |
| 86803 | <1% | 8,079 | $50K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,258 | $48K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 3,785 | $48K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 116 | $43K |
| 73630 | <1% | 5,135 | $42K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 126 | $41K |
| 76642 | <1% | 1,045 | $40K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,705 | $40K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 4,940 | $40K |
| 72100 | <1% | 1,974 | $39K | |
| 74018 | <1% | 1,619 | $39K | |
| 96415 | <1% | 1,025 | $39K | |
| 87428 | <1% | 1,125 | $38K | |
| 90732 | <1% | 627 | $38K | |
| G0400 | Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | <1% | 250 | $38K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | <1% | 13 | $37K |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | <1% | 170 | $35K |
| 86780 | <1% | 3,170 | $34K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 19,817 | $33K |
| 97165 | <1% | 1,567 | $33K | |
| 73610 | <1% | 4,369 | $32K | |
| 86706 | <1% | 4,531 | $32K | |
| 82607 | <1% | 5,100 | $31K | |
| 76536 | <1% | 624 | $31K | |
| 86704 | <1% | 3,891 | $31K | |
| 87340 | <1% | 5,829 | $31K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 196 | $30K |
| 96367 | <1% | 921 | $30K | |
| 73221 | <1% | 265 | $30K | |
| 64635 | <1% | 53 | $29K | |
| 73562 | <1% | 3,651 | $29K | |
| 64405 | <1% | 209 | $29K | |
| 62323 | <1% | 136 | $28K | |
| 10060 | <1% | 284 | $28K | |
| 73030 | <1% | 3,669 | $27K | |
| 86708 | <1% | 3,450 | $26K | |
| 73564 | <1% | 2,363 | $26K | |
| 83550 | <1% | 6,357 | $26K | |
| 85027 | <1% | 11,688 | $26K | |
| 71271 | <1% | 464 | $26K | |
| 83655 | <1% | 2,294 | $25K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 105 | $25K |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | <1% | 398 | $25K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,643 | $25K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,471 | $24K |
| 73110 | <1% | 3,166 | $23K | |
| 73130 | <1% | 3,335 | $22K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13,273 | $22K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 396 | $22K |
| 12001 | <1% | 514 | $22K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 2,004 | $22K |
| 84702 | <1% | 3,571 | $22K | |
| 84439 | <1% | 5,389 | $21K | |
| 83540 | <1% | 6,513 | $19K | |
| 97035 | <1% | 4,129 | $19K | |
| 73502 | <1% | 2,635 | $19K | |
| 87070 | <1% | 5,428 | $18K | |
| 59430 | <1% | 228 | $18K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 501 | $18K |
| 73140 | <1% | 1,862 | $17K | |
| 11721 | <1% | 4,422 | $17K | |
| 86480 | <1% | 438 | $17K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,818 | $17K |
| 87081 | <1% | 14,931 | $17K | |
| 84153 | <1% | 2,780 | $16K | |
| T1017 | Case management, billed per 15 minutes | <1% | 341 | $16K |
| 86787 | <1% | 1,645 | $16K | |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | <1% | 88 | $16K |
| 36591 | <1% | 1,489 | $16K | |
| 87209 | <1% | 1,096 | $15K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 321 | $14K |
| 72110 | <1% | 642 | $14K | |
| 73620 | <1% | 871 | $14K | |
| 86709 | <1% | 1,751 | $14K | |
| 82746 | <1% | 2,393 | $13K | |
| 97802 | <1% | 235 | $13K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 11,304 | $13K |
| 64490 | <1% | 27 | $13K | |
| 73600 | <1% | 518 | $13K | |
| Q3014 | Telehealth originating site facility fee | <1% | 923 | $13K |
| 74174 | <1% | 85 | $13K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 437 | $12K |
| 81001 | <1% | 19,549 | $12K | |
| 70486 | <1% | 204 | $12K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 230 | $12K |
| 99205 | Prolong outpt/office vis | <1% | 178 | $12K |
| 99443 | <1% | 508 | $12K | |
| 82043 | <1% | 5,205 | $11K | |
| 84403 | <1% | 719 | $11K | |
| 94726 | <1% | 1,475 | $11K | |
| 83970 | <1% | 762 | $11K | |
| 76770 | <1% | 206 | $11K | |
| 80076 | <1% | 2,842 | $11K | |
| 87186 | <1% | 6,179 | $11K | |
| 86140 | <1% | 6,508 | $10K | |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | <1% | 309 | $9K |
| 85610 | <1% | 11,821 | $9K | |
| 73080 | <1% | 1,176 | $8K | |
| 87205 | <1% | 7,221 | $8K | |
| 83880 | <1% | 2,758 | $8K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 980 | $8K |
| 93925 | <1% | 106 | $8K | |
| 83735 | <1% | 9,847 | $8K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 5,259 | $8K |
| 87088 | <1% | 4,663 | $8K | |
| 74178 | <1% | 39 | $8K | |
| 99220 | <1% | 81 | $8K | |
| 87522 | Neg quan hep c or qual rna | <1% | 329 | $8K |
| 80164 | <1% | 1,793 | $7K | |
| 87177 | <1% | 1,077 | $7K | |
| 87631 | <1% | 438 | $7K | |
| 99496 | <1% | 120 | $7K | |
| 80081 | <1% | 234 | $7K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,621 | $6K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 307 | $6K |
| 85660 | <1% | 1,382 | $6K | |
| G0378 | Hospital observation service, per hour | <1% | 10,807 | $6K |
| 77065 | Tomosynthesis, mammo | <1% | 145 | $6K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 486 | $6K |
| 82784 | <1% | 1,203 | $6K | |
| 72050 | <1% | 223 | $6K | |
| 82950 | <1% | 1,388 | $6K | |
| 81025 | <1% | 12,097 | $6K | |
| 86038 | <1% | 908 | $6K | |
| 99442 | <1% | 441 | $6K | |
| 93017 | <1% | 202 | $5K | |
| 64450 | <1% | 39 | $5K | |
| 97014 | <1% | 709 | $5K | |
| 87150 | <1% | 1,459 | $5K | |
| 86762 | <1% | 1,704 | $5K | |
| 51798 | <1% | 3,467 | $5K | |
| 80069 | <1% | 2,280 | $5K | |
| 85652 | <1% | 5,744 | $5K | |
| 80050 | General health panel | <1% | 177 | $5K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,530 | $5K |
| 29125 | <1% | 440 | $5K | |
| G0008 | Administration of influenza virus vaccine | <1% | 2,410 | $5K |
| 81003 | <1% | 11,393 | $5K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 306 | $4K |
| 86592 | <1% | 1,293 | $4K | |
| 64494 | <1% | 528 | $4K | |
| 95800 | <1% | 177 | $4K | |
| 93350 | <1% | 39 | $4K | |
| 95816 | <1% | 43 | $4K | |
| 69209 | <1% | 753 | $4K | |
| 90656 | <1% | 297 | $4K | |
| 77066 | Tomosynthesis, mammo | <1% | 54 | $4K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 40 | $4K |
| 76000 | <1% | 458 | $4K | |
| 86003 | <1% | 106 | $4K | |
| 83690 | <1% | 10,497 | $4K | |
| 0134A | <1% | 317 | $4K | |
| 83001 | <1% | 375 | $4K | |
| 95806 | <1% | 142 | $4K | |
| 99406 | <1% | 354 | $4K | |
| 99495 | <1% | 60 | $4K | |
| 99221 | <1% | 69 | $4K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 124 | $4K |
| 73590 | <1% | 399 | $4K | |
| 80178 | <1% | 1,309 | $3K | |
| 97803 | <1% | 101 | $3K | |
| 86618 | <1% | 764 | $3K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 1,265 | $3K |
| 0011A | <1% | 236 | $3K | |
| 20550 | <1% | 38 | $3K | |
| 99385 | <1% | 39 | $3K | |
| 93976 | <1% | 53 | $3K | |
| 86735 | <1% | 257 | $3K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 451 | $3K |
| 86705 | <1% | 388 | $3K | |
| 29075 | <1% | 28 | $3K | |
| 0012A | <1% | 218 | $3K | |
| G0009 | Administration of pneumococcal vaccine | <1% | 315 | $3K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 12 | $3K |
| 82570 | <1% | 1,612 | $3K | |
| 84146 | <1% | 218 | $2K | |
| 84703 | <1% | 2,231 | $2K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 40 | $2K |
| 86765 | <1% | 242 | $2K | |
| 77080 | <1% | 105 | $2K | |
| 72070 | <1% | 141 | $2K | |
| 87077 | <1% | 2,793 | $2K | |
| 70496 | <1% | 14 | $2K | |
| 95886 | <1% | 676 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 9,580 | $2K |
| 90662 | <1% | 1,117 | $2K | |
| 73090 | <1% | 183 | $2K | |
| 0124A | <1% | 165 | $2K | |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | <1% | 75 | $2K |
| 84100 | <1% | 1,896 | $2K | |
| 73560 | <1% | 289 | $2K | |
| 94729 | <1% | 1,704 | $2K | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 250 | $2K |
| 64483 | <1% | 12 | $2K | |
| 85018 | <1% | 2,148 | $2K | |
| 70491 | <1% | 13 | $2K | |
| 87338 | <1% | 194 | $2K | |
| 93923 | <1% | 39 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 169 | $2K |
| 76870 | <1% | 56 | $2K | |
| 0054A | <1% | 100 | $2K | |
| 86696 | <1% | 129 | $2K | |
| 0013A | <1% | 112 | $2K | |
| 85014 | <1% | 1,779 | $2K | |
| 82565 | <1% | 1,666 | $2K | |
| 95909 | <1% | 13 | $1K | |
| 83721 | <1% | 293 | $1K | |
| 86431 | <1% | 489 | $1K | |
| 85730 | <1% | 2,049 | $1K | |
| 93270 | <1% | 79 | $1K | |
| 0064A | <1% | 102 | $1K | |
| 83516 | <1% | 174 | $1K | |
| 80074 | <1% | 51 | $1K | |
| 84156 | <1% | 1,258 | $1K | |
| 84402 | <1% | 83 | $1K | |
| 12002 | <1% | 13 | $1K | |
| 86850 | <1% | 3,692 | $1K | |
| 84550 | <1% | 972 | $1K | |
| 71101 | <1% | 129 | $1K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,604 | $1K |
| 81002 | <1% | 5,436 | $1K | |
| 76775 | <1% | 28 | $1K | |
| 86200 | <1% | 247 | $1K | |
| 85379 | <1% | 2,617 | $1K | |
| 86695 | <1% | 129 | $1K | |
| 85045 | <1% | 610 | $1K | |
| 73700 | <1% | 28 | $1K | |
| 82947 | <1% | 424 | $1K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 98 | $1K |
| 17110 | <1% | 13 | $976.71 | |
| 86039 | <1% | 200 | $966.90 | |
| 87808 | <1% | 369 | $923.22 | |
| 76882 | <1% | 25 | $914.21 | |
| 83615 | <1% | 605 | $912.39 | |
| 58300 | <1% | 25 | $908.67 | |
| 90750 | <1% | 41 | $893.70 | |
| 96417 | <1% | 17 | $874.03 | |
| 90651 | <1% | 12 | $860.20 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 10,257 | $854.39 |
| 84460 | <1% | 616 | $850.15 | |
| 69210 | <1% | 87 | $835.83 | |
| 82550 | <1% | 707 | $812.27 | |
| 84165 | <1% | 258 | $801.67 | |
| 87040 | <1% | 3,740 | $799.15 | |
| 94618 | <1% | 117 | $780.82 | |
| 80156 | <1% | 169 | $743.58 | |
| 12011 | <1% | 46 | $719.25 | |
| 84484 | <1% | 9,648 | $686.32 | |
| 81000 | <1% | 2,671 | $663.82 | |
| 98927 | <1% | 38 | $652.10 | |
| 31575 | <1% | 26 | $647.93 | |
| 73521 | <1% | 31 | $636.90 | |
| 99224 | <1% | 40 | $621.61 | |
| 96523 | <1% | 56 | $605.16 | |
| 86666 | <1% | 212 | $600.48 | |
| 00126 | <1% | 151 | $579.62 | |
| 72131 | <1% | 14 | $552.38 | |
| 83605 | <1% | 4,327 | $537.50 | |
| 82962 | <1% | 13,581 | $522.98 | |
| 86235 | <1% | 15 | $487.70 | |
| 81596 | <1% | 12 | $454.77 | |
| 84450 | <1% | 355 | $444.03 | |
| 87493 | <1% | 100 | $431.82 | |
| 97166 | <1% | 13 | $428.44 | |
| 86901 | <1% | 3,893 | $427.10 | |
| 87469 | <1% | 80 | $423.94 | |
| 82075 | <1% | 3,751 | $402.61 | |
| 64447 | <1% | 49 | $394.57 | |
| 82785 | <1% | 63 | $377.62 | |
| 82103 | <1% | 90 | $373.63 | |
| 86364 | <1% | 63 | $363.02 | |
| 00811 | <1% | 12 | $357.41 | |
| 86430 | <1% | 167 | $357.36 | |
| 11055 | <1% | 28 | $351.44 | |
| 87484 | <1% | 60 | $336.79 | |
| 87468 | <1% | 60 | $336.79 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 33 | $335.64 |
| 88108 | <1% | 131 | $314.89 | |
| 86141 | <1% | 57 | $274.54 | |
| 85007 | <1% | 484 | $272.39 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 12 | $262.48 |
| 36592 | <1% | 72 | $257.26 | |
| 82670 | <1% | 14 | $251.46 | |
| 82378 | <1% | 55 | $250.31 | |
| 86376 | <1% | 28 | $246.53 | |
| 82077 | <1% | 1,623 | $245.97 | |
| 90670 | <1% | 16 | $239.45 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 144 | $237.95 |
| 86753 | <1% | 101 | $237.25 | |
| 87045 | <1% | 56 | $218.36 | |
| 87046 | <1% | 56 | $218.36 | |
| 73660 | <1% | 41 | $212.82 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 26 | $209.96 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 5,213 | $206.12 |
| 82104 | <1% | 40 | $197.45 | |
| 90715 | <1% | 4,203 | $193.42 | |
| 73120 | <1% | 13 | $188.97 | |
| 99441 | <1% | 29 | $188.63 | |
| 84520 | <1% | 210 | $186.79 | |
| 0031A | <1% | 60 | $183.47 | |
| 83921 | <1% | 30 | $162.53 | |
| 0001A | <1% | 138 | $158.80 | |
| 99024 | <1% | 404 | $150.45 | |
| 82105 | <1% | 25 | $138.99 | |
| 82533 | <1% | 31 | $130.40 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 13,119 | $130.04 |
| 83021 | <1% | 13 | $129.22 | |
| 88112 | <1% | 14 | $120.96 | |
| 72275 | <1% | 289 | $113.37 | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 12 | $107.82 |
| 72170 | <1% | 22 | $107.22 | |
| 92504 | <1% | 56 | $107.00 | |
| 90734 | <1% | 12 | $97.49 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 1,860 | $96.19 |
| 82150 | <1% | 112 | $95.92 | |
| 80143 | <1% | 288 | $93.20 | |
| 86617 | <1% | 19 | $92.94 | |
| 83020 | <1% | 13 | $92.12 | |
| 76376 | <1% | 648 | $88.67 | |
| 87478 | <1% | 60 | $87.72 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 1,100 | $77.56 |
| 82803 | <1% | 304 | $74.97 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 11,071 | $72.70 |
| 83521 | <1% | 14 | $72.54 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 4,657 | $70.95 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 11,338 | $65.55 |
| 80175 | <1% | 12 | $55.22 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,525 | $54.79 |
| 97116 | <1% | 58 | $53.66 | |
| 80179 | <1% | 189 | $46.60 | |
| 97597 | <1% | 15 | $45.21 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 4,390 | $40.39 |
| 88304 | <1% | 98 | $36.58 | |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | <1% | 901 | $35.71 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 643 | $35.70 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 7,893 | $34.85 |
| 0004A | <1% | 36 | $31.58 | |
| 84132 | <1% | 13 | $30.83 | |
| J2704 | Injection, propofol, 10 mg | <1% | 12,607 | $30.48 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 4,569 | $29.87 |
| 98928 | <1% | 14 | $26.23 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 276 | $25.91 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,197 | $25.57 |
| 93356 | <1% | 139 | $22.47 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 2,933 | $21.50 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 217 | $21.37 |
| G0238 | Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring) | <1% | 15 | $19.59 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 2,241 | $12.79 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 5,311 | $12.46 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 1,009 | $12.26 |
| 87075 | <1% | 25 | $9.17 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,423 | $7.93 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,572 | $7.20 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,493 | $5.83 |
| 97010 | <1% | 1,361 | $3.34 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,758 | $2.76 |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 617 | $2.15 |
| J3490 | Unclassified drugs | <1% | 2,376 | $0.18 |
| J7609 | Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg | <1% | 80 | $0.03 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 5,328 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 737 | $0.00 |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 707 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 1,986 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 323 | $0.00 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 0% | 1,163 | $0.00 |
| 1090F | 0% | 266 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 257 | $0.00 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 1,078 | $0.00 |
| 76942 | 0% | 197 | $0.00 | |
| 00812 | 0% | 428 | $0.00 | |
| A6451 | Moderate compression bandage, elastic, knitted/woven, load resistance of 1.25 to 1.34 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard | 0% | 280 | $0.00 |
| 3078F | 0% | 1,500 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 0% | 168 | $0.00 |
| 99152 | 0% | 212 | $0.00 | |
| J1020 | Injection, methylprednisolone acetate, 20 mg | 0% | 235 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 175 | $0.00 |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 0% | 35 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 0% | 572 | $0.00 |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 0% | 14 | $0.00 |
| 91312 | 0% | 168 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 127 | $0.00 |
| 3023F | 0% | 173 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 102 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 365 | $0.00 |
| 01810 | 0% | 25 | $0.00 | |
| 00731 | 0% | 92 | $0.00 | |
| A6210 | Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing | 0% | 155 | $0.00 |
| 82010 | 0% | 217 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 245 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 88 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 186 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 317 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 54 | $0.00 |
| 91313 | 0% | 318 | $0.00 | |
| 77002 | 0% | 145 | $0.00 | |
| 0002A | 0% | 125 | $0.00 | |
| 4004F | 0% | 59 | $0.00 | |
| 2022F | 0% | 183 | $0.00 | |
| A4248 | Chlorhexidine containing antiseptic, 1 ml | 0% | 22 | $0.00 |
| A6209 | Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | 0% | 55 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 41 | $0.00 |
| G0473 | Face-to-face behavioral counseling for obesity, group (2-10), 30 minutes | 0% | 60 | $0.00 |
| 64636 | 0% | 27 | $0.00 | |
| 94664 | 0% | 32 | $0.00 | |
| 3046F | 0% | 65 | $0.00 | |
| 3077F | 0% | 69 | $0.00 | |
| 1160F | 0% | 14 | $0.00 | |
| 1159F | 0% | 58 | $0.00 | |
| G8400 | Patient with central dual-energy x-ray absorptiometry (dxa) results not documented, reason not given | 0% | 31 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 28 | $0.00 |
| 1123F | 0% | 2,432 | $0.00 | |
| 3074F | 0% | 1,103 | $0.00 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 983 | $0.00 |
| 94760 | 0% | 941 | $0.00 | |
| 3017F | 0% | 2,233 | $0.00 | |
| 1036F | 0% | 3,047 | $0.00 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 1,612 | $0.00 |
| 3079F | 0% | 346 | $0.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 753 | $0.00 |
| 36416 | 0% | 501 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 2,342 | $0.00 |
| A9270 | Non-covered item or service | 0% | 8,230 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 170 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 318 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 4,463 | $0.00 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 0% | 28 | $0.00 |
| 96376 | 0% | 2,210 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 916 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 634 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 1,220 | $0.00 |
| 91305 | 0% | 181 | $0.00 | |
| C9290 | Injection, bupivacaine liposome, 1 mg | 0% | 626 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 141 | $0.00 |
| A4217 | Sterile water/saline, 500 ml | 0% | 131 | $0.00 |
| 80359 | 0% | 26 | $0.00 | |
| 00813 | 0% | 181 | $0.00 | |
| G8428 | Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given | 0% | 82 | $0.00 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 32 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 81 | $0.00 |
| C1769 | Guide wire | 0% | 486 | $0.00 |
| 3075F | 0% | 162 | $0.00 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 126 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 2,899 | $0.00 |
| 36000 | 0% | 32 | $0.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 208 | $0.00 |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 0% | 197 | $0.00 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 83 | $0.00 |
| 91306 | 0% | 98 | $0.00 | |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 54 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 0% | 124 | $0.00 |
| 70498 | 0% | 14 | $0.00 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 66 | $0.00 |
| 94761 | 0% | 173 | $0.00 | |
| C9399 | Unclassified drugs or biologicals | 0% | 18 | $0.00 |
| 95885 | 0% | 13 | $0.00 | |
| 3044F | 0% | 28 | $0.00 | |
| 80324 | 0% | 26 | $0.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 12 | $0.00 |
| 88342 | 0% | 12 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 15 | $0.00 |
| 01480 | 0% | 59 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 0% | 91 | $0.00 |
| 97535 | Self-care/home management training, each 15 minutes | 0% | 55 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWOOD, JOSEPH (CFO)